Sydney Vital Flagship 3 research fellow Dr Yaser Gholami received a Beryl & Jack Jacobs Travel Award from the Kolling Institute in May 2019. The travel award enabled Dr Gholami to travel to the Harvard Medical School/Massachusetts General Hospital (MGH) as a visiting scholar and to further enhance the existing collaboration on developing a novel theranostic radio-immuno-nanoplatform for multimodal imaging and targeted radionuclide therapy of cancer.
During Dr Gholami’s 5 week visit to the Harvard Medical School/MGH, he was allocated a desk and laboratory space at MGH Navy Yard campus to perform a number of important experiments related to: 1- Nanomedicine technology innovation, 2- Investigating Dr Gholami’s novel theory in nuclear imaging and therapy. These included;
- Performing non-radioactive and radioactive isotope-nanoparticle radiolabelling for further physical (i.e. Heat Induced radiolabelling, Nuclear magnetic relaxation spectroscopy and dynamic light scattering) and chemical (i.e. inductively coupled plasma mass spectrometry) characterisation of their developed nanomedicine platform.
- Dr Gholami contributed to a Monkey study performed by the MGH collaborators. This animal study involved using our nanotechnology for positron emission tomography (PET) and magnetic resonance imaging (MRI).
- Performing a separate experiment to investigate a novel theory in nuclear therapy and imaging using the clinical PET/MRI scanner at MGH.
The above experiments have enabled Dr Gholami to practice and be trained on the clinical PET/MRI scanner which can be beneficial in near future since it is hoped that a clinical PET/MRI scanner will soon be installed at the Royal North Shore Hospital (where Dr Gholami is based). Results from these experiments were also necessary for the manuscript submission by Dr Gholami and other researchers.
On 19th August 2019, as a result of the Sydney Vital research funding and the extensive research undertaken, Dr Gholami submitted the manuscript titled “A Novel Chelate-Free Theranostic Nano-platform” to the International Journal of Nanomedicine.
Sydney Vital would like to congratulate Dr Gholami on his successful visit to Harvard Medical School / MGH and look forward to seeing more translational cancer research outcomes from his project under our flagship program.
Keep up-to-date with our scholarships, funding and awards and check out our grant schemes here.